Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
If you or someone you know has diabetes, you’ve likely heard of metformin, a drug that’s primarily prescribed to support ...
Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...
The consensus estimates suggest we should see a major improvement in the supply of FDA-approved weight loss drugs in the first half of 2025. Even when the shortages are over, the FDA allows legal ...
Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...